Obesity Weekly News – July 29th 2025 Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic Wegovy Win & More In this week’s Obesity Updates, we […] The post Obesity Weekly News – July 29th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Obesity Weekly News – July 29th 2025 #News #ASC30 #glp1 #ObesityResearch #RochePharma Comment below!

Obesity Weekly News – July 29th 2025 Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic Wegovy Win & More In this week’s Obesity Updates, we […] The post Obesity Weekly News – July 29th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Obesity Weekly News – July 29th 2025 #News #ASC30 #glp1 #ObesityResearch #RochePharma Comment below!

Obesity Weekly News – July 29th 2025 Obesity Update: Once-Monthly ASC30 Trial, Viking’s Phase III Launch, Generic Wegovy Win & More In this week’s Obesity Updates, we […] The post Obesity Weekly News – July 29th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Obesity Weekly News – July 29th 2025 #News #ASC30 #glp1 #ObesityResearch #RochePharma Comment below!

‘Een medicijn ontwikkelen is een proces van eindeloze een-tweetjes’ ‘Medicijnen ontwikkelen bij Roche is schaken in een matrix van twaalf dimensies’, zegt Hans Clevers, hoogleraar moleculaire genetica.

‘Een medicijn ontwikkelen is een proces van eindeloze een-tweetjes’
⁠
‘Lees het volledige artikel op onze website, in de app of via de link🔗 in onze bio!’⁠

📸Roche

#MedicijnOntwikkeling #HansClevers #MoleculaireGenetica #InnovatieInGezondheid #RochePharma
⁠
www.newscientist.nl/blogs/een-me...